Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

Clinical trial NCT07665684 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07665684
Sponsor: University Health Network, Toronto
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreas Ductal Adenocarcinoma Pancreas Cancer, Metastatic Pancreatic Adenocarcinoma Metastatic Adenosquamous Carcinoma of the Pancreas Mucinous Adenocarcinoma

Start date: 2026-07-01
Primary completion: 2029-05-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.